Uterine Fibroids

Elagolix + Add-Back Tx Reduces Heavy Menstrual Bleeding in Phase 3 Extension Study

By August 23, 2018

AbbVie plans to submit data from the phase 3 uterine fibroids program to the FDA sometime in 2019.

First-in-Class Oral Tx for Uterine Fibroids One Step Closer to Approval

By October 10, 2017

Ulipristal acetate is a selective progesterone receptor modulator which acts directly on the progesterone receptors in the endometrium, uterine fibroids, and the pituitary gland.